Clostridioides difficile infection in children: Recent updates on epidemiology, diagnosis, therapy

DA Shirley, W Tornel, CA Warren, S Moonah - Pediatrics, 2023 - publications.aap.org
Clostridioides (formerly Clostridium) difficile is the most important infectious cause of
antibiotic-associated diarrhea worldwide and a leading cause of healthcare-associated …

Clostridium (Clostridioides) difficile in animals

JS Weese - Journal of veterinary diagnostic investigation, 2020 - journals.sagepub.com
Clostridium (Clostridioides) difficile is a gram-positive, spore-forming bacterium that is an
important cause of disease in people, a variably important cause of disease in some animal …

Proton pump inhibitor use and risk of serious infections in young children

M Lassalle, M Zureik, R Dray-Spira - JAMA pediatrics, 2023 - jamanetwork.com
Importance Proton pump inhibitor (PPI) use may lead to infections through alteration of the
microbiota or direct action on the immune system. However, only a few studies were …

A narrative review on efficacy and safety of proton pump inhibitors in children

V Dipasquale, G Cicala, E Spina… - Frontiers in …, 2022 - frontiersin.org
Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include
omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. Their use in …

Bacterial gut microbiota and infections during early childhood

S George, X Aguilera, P Gallardo, M Farfán… - Frontiers in …, 2022 - frontiersin.org
Gut microbiota composition during the first years of life is variable, dynamic and influenced
by both prenatal and postnatal factors, such as maternal antibiotics administered during …

Epidemiological and microbiome associations of Clostridioides difficile carriage in infancy and early childhood

J Mani, S Levy, A Angelova, S Hazrati, R Fassnacht… - Gut …, 2023 - Taylor & Francis
There has been an increase in the prevalence of Clostridioides difficile (C. diff) causing
significant economic impact on the health care system. Although toxigenic C. diff carriage is …

[HTML][HTML] Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis

N Dong, ZR Li, P Qin, CX Qiang, J Yang, YN Niu… - Journal of Hospital …, 2022 - Elsevier
Background Clostridioides difficile is considered an urgent threat to human health by the US
Centers for Disease Control and Prevention. In recent years, C. difficile has been reported …

A review of histamine-2 receptor antagonist and proton pump inhibitor therapy for gastroesophageal reflux disease in neonates and infants

J Tan, S Jeffries, R Carr - Pediatric Drugs, 2023 - Springer
Proton pump inhibitors (PPI) and histamine-2 receptor antagonists (H2RA) are commonly
used medications in neonates and infants for the treatment of gastroesophageal reflux …

Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

AK Dutta, A Jain, V Jearth, R Mahajan… - Indian Journal of …, 2023 - Springer
Proton pump inhibitors (PPIs) have been available for over three decades and are among
the most commonly prescribed medications. They are effective in treating a variety of gastric …

Clostridioides difficile infection in hospitalized pediatric patients: comparisons of epidemiology, testing, and treatment from 2013 to 2019

PT Edwards, CW Thurm, M Hall, JD Busing… - The Journal of …, 2023 - Elsevier
Objectives To compare the incidence, epidemiology, testing patterns, treatment, and
outcomes of Clostridioides difficile infection (CDI) among hospitalized pediatric patients from …